Shanghai Haohai Biological Technology Co (SHSE:688366) LT-Debt-to-Total-Asset: 0.00 (As of Mar. 2026)

What is Shanghai Haohai Biological Technology Co LT-Debt-to-Total-Asset?

Shanghai Haohai Biological Technology Co SHSE:688366 +6.17% 73 LT-Debt-to-Total-Asset is 0.00 as of Mar. 2026. GuruFocus rates SHSE:688366 with a GF Score™ of 73/100 and a GF Value™ of ¥47.40 (Significantly Undervalued). The stock has 5 warning signs investors should review.

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Shanghai Haohai Biological Technology Co's long-term debt to total assests ratio for the quarter that ended in Mar. 2026 was 0.00.

Shanghai Haohai Biological Technology Co's long-term debt to total assets ratio declined from Dec. 2024 (0.02) to Mar. 2026 (0.00). It may suggest that Shanghai Haohai Biological Technology Co is progressively becoming less dependent on debt to grow their business.

Shanghai Haohai Biological Technology Co (SHSE:688366) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Shanghai Haohai Biological Technology Co LT-Debt-to-Total-Asset Related Terms

Shanghai Haohai Biological Technology Co LT-Debt-to-Total-Asset Historical Data

* Premium members only.

The historical data trend for Shanghai Haohai Biological Technology Co's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai Haohai Biological Technology Co LT-Debt-to-Total-Asset Chart

Shanghai Haohai Biological Technology Co Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.01

0.03

0.02

0.01

Shanghai Haohai Biological Technology Co Quarterly Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Jun25	Sep25	Dec25	Mar26
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															0.02	0.02	0.02	0.01	0.00

73GF Score

Shanghai Haohai Biological Technology Co Ltd SHSE:688366

LT-Debt-to-Total-Asset is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Shanghai Haohai Biological Technology Co LT-Debt-to-Total-Asset Calculation

Shanghai Haohai Biological Technology Co's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as

LT Debt to Total Assets (A: Dec. 2025 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2025 )	/	Total Assets (A: Dec. 2025 )
	=	63.906	/	6720.063
	=	0.01

Shanghai Haohai Biological Technology Co's Long-Term Debt to Total Asset Ratio for the quarter that ended in Mar. 2026 is calculated as

LT Debt to Total Assets (Q: Mar. 2026 )	=	Long-Term Debt & Capital Lease Obligation (Q: Mar. 2026 )	/	Total Assets (Q: Mar. 2026 )
	=	26.442	/	6666.309
	=	0.00

Frequently Asked Questions Learn more about LT-Debt-to-Total-Asset →

What does a LT-Debt-to-Total-Asset of 0.00 mean?

Shanghai Haohai Biological Technology Co (SHSE:688366) has a LT-Debt-to-Total-Asset of 0.00 as of Mar. 2026. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Shanghai Haohai Biological Technology Co and its competitors.

Is Shanghai Haohai Biological Technology Co's LT-Debt-to-Total-Asset too high?

Shanghai Haohai Biological Technology Co's current LT-Debt-to-Total-Asset is 0.00. Overall, Shanghai Haohai Biological Technology Co has a GF Score™ of 73/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.

How does Shanghai Haohai Biological Technology Co's LT-Debt-to-Total-Asset compare to VRTX and REGN?

Shanghai Haohai Biological Technology Co's LT-Debt-to-Total-Asset of 0.00 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good LT-Debt-to-Total-Asset for a Biotechnology company?

A good LT-Debt-to-Total-Asset depends on the Biotechnology industry context. However, LT-Debt-to-Total-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high LT-Debt-to-Total-Asset mean?

A high LT-Debt-to-Total-Asset can signal that a stock is expensive relative to its fundamentals. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Shanghai Haohai Biological Technology Co and its competitors. Shanghai Haohai Biological Technology Co's current LT-Debt-to-Total-Asset is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Shanghai Haohai Biological Technology Co stock overvalued right now?

Based on GuruFocus' analysis, Shanghai Haohai Biological Technology Co (SHSE:688366) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥47.40, compared to a current price of ¥32.03 — trading 32.4% below its estimated fair value. The current LT-Debt-to-Total-Asset is 0.00. Shanghai Haohai Biological Technology Co's overall GF Score™ is 73/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is LT-Debt-to-Total-Asset calculated?

LT-Debt-to-Total-Asset is calculated from a company's financial statements. For Shanghai Haohai Biological Technology Co (SHSE:688366), the current LT-Debt-to-Total-Asset is 0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shanghai Haohai Biological Technology Co (SHSE:688366) Overvalued in 2026?

Based on GuruFocus' analysis, Shanghai Haohai Biological Technology Co stock appears to be undervalued. The current stock price of ¥32.03 is trading 32.4% below its estimated GF Value™ of ¥47.40. GuruFocus considers Shanghai Haohai Biological Technology Co to be Significantly Undervalued.

Key valuation signals for SHSE:688366:

LT-Debt-to-Total-Asset: 0.00
GF Value™: ¥47.40 vs. price of ¥32.03 (32.4% below fair value)
GF Score™: 73/100 with 5 warning signs

No single metric tells the full story. See the SHSE:688366 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Shanghai Haohai Biological Technology Co Business Description

Industry Healthcare Biotechnology

Comparable Companies HKSE:09966 HKSE:02157 HKSE:02256 HKSE:02659 HKSE:02616 HKSE:00775 HKSE:06938 HKSE:02171 HKSE:02617 HKSE:01952 VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY ASX:CSL RVMD ONC MRNA

Other Exchanges 06826:Hong Kong 5HB:Germany

Address No. 1386 Hongqiao Road, 23rd Floor, WenGuang Plaza, Changning District, Shanghai, CHN

Website https://www.3healthcare.com

Shanghai Haohai Biological Technology Co Ltd is engaged in the manufacturing and sale of biologicals, medical hyaluronate, and ophthalmology products. The Company's operating activities are related to a single operating segment, which is the manufacture and sale of biologicals, medical hyaluronate, and intraocular lenses, research and development of biological engineering and pharmaceutical products, and the provision of related services. Its products are categorized into four types, comprising ophthalmology, medical aesthetics, orthopedics, and anti-adhesion. Geographically, it has operations in Mainland China, which is the key revenue driver, the United States, the United Kingdom, and other countries.

73GF Score

Get the complete analysis for SHSE:688366

LT-Debt-to-Total-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥32.03

Price

¥47.40

GF Value

View SHSE:688366 Analysis

See LT-Debt-to-Total-Asset data for all stocks →